Reprogramming chronic wounds: the emerging role of microbiome-targeted therapies in diabetic foot ulcers.

Kamal R, Chauhan A, Bhargava SK, Dhiman S, Singh TG, Kumar D, Awasthi A

Open source

DOI
10.1016/j.ijpharm.2026.127137
Published
2026 Aug 10
Container
International journal of pharmaceutics
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.127137,
  title = {Reprogramming chronic wounds: the emerging role of microbiome-targeted therapies in diabetic foot ulcers.},
  author = {Kamal R and Chauhan A and Bhargava SK and Dhiman S and Singh TG and Kumar D and Awasthi A},
  year = {2026},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.127137},
  url = {https://doi.org/10.1016/j.ijpharm.2026.127137}
}

RIS

TY  - JOUR
TI  - Reprogramming chronic wounds: the emerging role of microbiome-targeted therapies in diabetic foot ulcers.
AU  - Kamal R
AU  - Chauhan A
AU  - Bhargava SK
AU  - Dhiman S
AU  - Singh TG
AU  - Kumar D
AU  - Awasthi A
PY  - 2026
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2026.127137
UR  - https://doi.org/10.1016/j.ijpharm.2026.127137
ER  - 

APA

R, K., A, C., SK, B., S, D., TG, S., D, K., & A, A. (2026). Reprogramming chronic wounds: the emerging role of microbiome-targeted therapies in diabetic foot ulcers.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127137

Source records